Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ulocuplumab

EU orphan designation number: EU/3/15/1445   
Active ingredient: Ulocuplumab
Indication: Treatment of acute myeloid leukaemia
Sponsor: Bristol-Myers Squibb Pharma EEIG
Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/258/14 (2015)960 of 12/02/2015